RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on November 25 and set a price target of $50.00. The ...

On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $42.05 which represents a decrease of $-1.61 or -3.69% from the prior close of $43.66. The stock opened at $43.13 and touched a ...

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...